NasdaqGS - Nasdaq Real Time Price USD

CARGO Therapeutics, Inc. (CRGX)

4.0200
-0.1000
(-2.43%)
At close: May 9 at 4:00:00 PM EDT
4.0989
+0.08
+(1.96%)
After hours: May 9 at 7:53:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
187,370
187,370
96,710
34,771
5,977
Operating Income
-187,370
-187,370
-96,710
-34,771
-5,977
Net Non Operating Interest Income Expense
20,063
20,063
3,267
-4,942
0
Other Income Expense
-195
-195
-4,704
-1,238
127
Pretax Income
-167,502
-167,502
-98,147
-40,951
-5,850
Net Income Common Stockholders
-167,502
-167,502
-98,147
-40,951
-5,850
Diluted NI Available to Com Stockholders
-167,502
-167,502
-98,147
-40,951
-5,850
Basic EPS
-3.72
--
-16.53
-2.10
-0.30
Diluted EPS
-3.72
--
-16.53
-2.10
-0.30
Basic Average Shares
44,969.6430
--
5,938.7820
19,471.2650
19,471.2650
Diluted Average Shares
44,969.6430
--
5,938.7820
19,471.2650
19,471.2650
Total Operating Income as Reported
-187,370
-187,370
-96,710
-34,771
-5,977
Total Expenses
187,370
187,370
96,710
34,771
5,977
Net Income from Continuing & Discontinued Operation
-167,502
-167,502
-98,147
-40,951
-5,850
Normalized Income
-167,502
-167,502
-102,284
-39,735
-5,850
Interest Income
20,063
20,063
4,871
--
--
Interest Expense
0
0
1,604
4,942
0
Net Interest Income
20,063
20,063
3,267
-4,942
0
EBIT
-167,502
-167,502
-96,543
-36,009
-5,850
EBITDA
-160,428
-160,428
-92,851
-34,565
-5,703
Reconciled Depreciation
7,074
7,074
3,692
1,444
147
Net Income from Continuing Operation Net Minority Interest
-167,502
-167,502
-98,147
-40,951
-5,850
Total Unusual Items Excluding Goodwill
0
0
4,137
-1,216
--
Total Unusual Items
0
0
4,137
-1,216
--
Normalized EBITDA
-160,428
-160,428
-96,988
-33,349
-5,703
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/13/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HLVX HilleVax, Inc.
1.9000
-0.52%
 
EPIX ESSA Pharma Inc.
1.7200
+0.58%
 
ANTX AN2 Therapeutics, Inc.
1.2000
-1.64%
 
KZR Kezar Life Sciences, Inc.
4.2200
+2.43%
 
IKNA Ikena Oncology, Inc.
1.1300
+4.63%
 
TBPH Theravance Biopharma, Inc.
8.98
-9.29%
 
SPRO Spero Therapeutics, Inc.
0.6200
+7.83%
 
IPSC Century Therapeutics, Inc.
0.5370
+3.27%
 
GLTO Galecto, Inc.
2.7450
-1.96%
 
SEER Seer, Inc.
1.8400
-2.65%